NDLI: Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert

Content Provider	Springer Nature : BioMed Central
Author	Jordan, Sue Bromley, Rebecca Damase-Michel, Christine Given, Joanne Komninou, Sophia Loane, Maria Marfell, Naomi Dolk, Helen
Abstract	Background The pharmacoepidemiology of the long-term benefits and harms of medicines in pregnancy and breastfeeding has received little attention. The impact of maternal medicines on children is increasingly recognised as a source of avoidable harm. The focus of attention has expanded from congenital anomalies to include less visible, but equally important, outcomes, including cognition, neurodevelopmental disorders, educational performance, and childhood ill-health. Breastfeeding, whether as a source of medicine exposure, a mitigator of adverse effects or as an outcome, has been all but ignored in pharmacoepidemiology and pharmacovigilance: a significant ‘blind spot’. Whole-population data on breastfeeding: why we need them Optimal child development and maternal health necessitate breastfeeding, yet little information exists to guide families regarding the safety of medicine use during lactation. Breastfeeding initiation or success may be altered by medicine use, and breastfeeding may obscure the true relationship between medicine exposure during pregnancy and developmental outcomes. Absent or poorly standardised recording of breastfeeding in most population databases hampers analysis and understanding of the complex relationships between medicine, pregnancy, breastfeeding and infant and maternal health. The purpose of this paper is to present the arguments for breastfeeding to be included alongside medicine use and neurodevelopmental outcomes in whole-population database investigations of the harms and benefits of medicines during pregnancy, the puerperium and postnatal period. We review: 1) the current situation, 2) how these complexities might be accommodated in pharmacoepidemiological models, using antidepressants and antiepileptics as examples; 3) the challenges in obtaining comprehensive data. Conclusions The scarcity of whole-population data and the complexities of the inter-relationships between breastfeeding, medicines, co-exposures and infant outcomes are significant barriers to full characterisation of the benefits and harms of medicines during pregnancy and breastfeeding. This makes it difficult to answer the questions: ‘is it safe to breastfeed whilst taking this medicine’, and ‘will this medicine interfere with breastfeeding and/ or infants’ development’?
Related Links	https://internationalbreastfeedingjournal.biomedcentral.com/counter/pdf/10.1186/s13006-022-00494-5.pdf
Ending Page	17
Page Count	17
Starting Page	1
File Format	HTM / HTML
ISSN	17464358
DOI	10.1186/s13006-022-00494-5
Journal	International Breastfeeding Journal
Issue Number	1
Volume Number	17
Language	English
Publisher	BioMed Central
Publisher Date	2022-08-02
Access Restriction	Open
Subject Keyword	Maternal and Child Health Breastfeeding Pharmacoepidemiology Pharmacovigilance Pregnancy Child development Adverse drug reactions
Content Type	Text
Resource Type	Article
Subject	Obstetrics and Gynecology Pediatrics, Perinatology and Child Health
Journal Impact Factor	2.9/2023
5-Year Journal Impact Factor	3.6/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disorders

Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres

Postpartum women’s use of medicines and breastfeeding practices: a systematic review

Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.

First trimester medication use in pregnancy in Cameroon: a multi-hospital survey

Breastfeeding as a balancing act – pregnant Swedish women’s voices on breastfeeding

Commentary on the article “Postpartum women’s use of medicines and breastfeeding practices: a systematic review”

Avoiding risk at what cost? Putting use of medicines for breastfeeding women into perspective

Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction Reports.

Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert

Similar Documents

Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disorders

Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres

Postpartum women’s use of medicines and breastfeeding practices: a systematic review

Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.

First trimester medication use in pregnancy in Cameroon: a multi-hospital survey

Breastfeeding as a balancing act – pregnant Swedish women’s voices on breastfeeding

Commentary on the article “Postpartum women’s use of medicines and breastfeeding practices: a systematic review”

Avoiding risk at what cost? Putting use of medicines for breastfeeding women into perspective

Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction Reports.

Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert